Pfizer
DC · US
Tracked giving exceeds tracked receipts by
$1,520,000
One of the world's largest pharmaceutical companies ($58.5 billion revenue in 2023). Maker of the COVID-19 vaccine (Comirnaty), Paxlovid, and extensive oncology portfolio.
Tracked direct giving
$1,520,000
Tracked donations to candidate
$0
Connections
13
Coalition view
Pfizer operates as part of a multi-committee coalition with Pfizer Inc. PAC. Combined tracked totals across all coalition members below give the figure most public sources quote (Sludge, JNS, OpenSecrets).
Combined tracked giving
$4,173,540
Combined tracked receipts
$230,763
How money flowed from Pfizer
Pfizer directed $2.0M to Trump Inaugural Committee (2025) across 2 contributions. Pfizer opposes Medicare Drug Price Negotiation - First 10 Drugs Selected.
Pfizer directed $1.0M to American Enterprise Institute across 2 contributions. Pfizer opposes Medicare Drug Price Negotiation - First 10 Drugs Selected.
Pfizer directed $40K to Mark Green across 2 contributions. Pfizer opposes Medicare Drug Price Negotiation - First 10 Drugs Selected.
Government Contracts Received
Total tracked contract value
$40.6B
(15 awards)
| Agency | Amount | Type | Date | Source |
|---|---|---|---|---|
| Department of Defense | $12.5B | — | Nov 2021 | USASpending |
| Department of Defense | $11.1B | — | Dec 2020 | USASpending |
| Agency for International Development | $4.2B | — | Jul 2021 | USASpending |
| Department of Defense | $4.0B | — | Jun 2022 | USASpending |
| Department of Health and Human Services | $1.2B | — | Apr 2010 | USASpending |
| Department of Health and Human Services | $1.0B | — | Apr 2011 | USASpending |
| Department of Health and Human Services | $1.0B | — | Apr 2014 | USASpending |
| Department of Health and Human Services | $1.0B | — | Apr 2017 | USASpending |
| Department of Health and Human Services | $976.9M | — | Apr 2012 | USASpending |
| Department of Health and Human Services | $925.3M | — | Apr 2013 | USASpending |
| Department of Health and Human Services | $683.6M | — | Apr 2008 | USASpending |
| Department of Health and Human Services | $668.2M | — | Apr 2009 | USASpending |
| Department of Health and Human Services | $585.7M | — | Apr 2007 | USASpending |
| Department of Health and Human Services | $533.9M | — | Mar 2006 | USASpending |
| Agency for International Development | $89.1M | — | Sep 2004 | USASpending |
Data from USASpending.gov. Amounts reflect award values at time of obligation.
Recent News
ORIC stock gains as Stifel resumes at Buy ( ORIC : NASDAQ )
NPPA hikes Cisplatin and Carboplatin prices by 50 % amid cancer drug shortage
North East and Yorkshire NHS teams win three Excellence Awards
Forget Eli Lilly and Company : As June Volatility Rocks High - Flyers , This Stock Is a No - Brainer Buy
Pfizer Inc . $PFE Shares Bought by Xponance LLC
News articles sourced from GDELT Project. Tone analysis is automated and approximate.
Click a node to see details
Double-click to expand its connections
Donations Given
| Recipient | Amount | Date | Cycle |
|---|---|---|---|
| Trump Inaugural Committee (2025) | $1,000,000 | Dec 19, 2024 | 2024 |
| American Enterprise Institute | $500,000 | Jan 1, 2015 | 2016 |
| Mark Green | $20,000 | Feb 1, 2023 | 2024 |
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| commented_on | Centers for Medicare & Medicaid Services | Public comment on CMS-2023-0191: Patient Protection and Affordable Care Act, Notice of Benefit and Payment Parameters for 2025; Updating Waiver Public Notice Procedures; Medicaid; Con | Source |
| Lobbied for | MARCH-IN Rights Proposal (NIH Framework) | LDA filing: lobbied on NIH March-In Rights, period 1st Quarter (Jan 1 - Mar 31), reported amount $60,000 | Source |
| Employed by | THE DUBERSTEIN GROUP INC. | Hired THE DUBERSTEIN GROUP INC. to lobby on NIH March-In Rights | Source |
| Employed by | MARSHALL & POPP, LLC | Hired MARSHALL & POPP, LLC to lobby on Pharmaceuticals | Source |
| Employed by | THE WASHINGTON TAX & PUBLIC POLICY GROUP | Hired THE WASHINGTON TAX & PUBLIC POLICY GROUP to lobby on Lower Energy Costs Act | Source |
| Funded research at | The Brookings Institution | Pfizer corporate donor to Brookings health policy program | Editorial |
| Funded research at | American Enterprise Institute | Pfizer corporate donor to AEI health policy research | Editorial |
| Coalition with | Pharmaceutical industry | Pfizer is one of the world's largest pharmaceutical companies and a key PhRMA member | Editorial |
| Opposed | Medicare Drug Price Negotiation - First 10 Drugs Selected | Pfizer opposed Medicare drug price negotiation under the Inflation Reduction Act. | Source |
| Has as instrument | Pfizer Inc. PAC | Pfizer PAC is the political arm of Pfizer Inc. | Editorial |
| Employed | Albert Bourla | Chairman and CEO of Pfizer since 2019 | Editorial |
| Parent of | Pfizer Inc. PAC | Pfizer Inc. PAC is the federal political action committee of Pfizer Inc. | Source |
| Stock held by | Mark Green | Mark Green holds PFE stock (1 disclosed transactions) | Source |